Not so long, as we are already in Q3FY24 !!!
Stated in the report: The Company, along with it's regulatory partners, received feedback late in the Quarter, and held a meeting with the FDA regarding a Q-submission the Company made for an alternate fluorescein contrast agent for oral use, and associated qualitative studies with regards to the interpretability of digital images in the oral cavity. The FDA have allowed for additional clarification and feedback to be provided in written form, which will be provided in Q3FY24.
We are now in Q3FY24 !!!!!
FDA submission and approval will happen this Calendar Year in 2024 in my opinion!
Not so long, as we are already in Q3FY24 !!! :)Stated in the...
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $116.9M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $14.96K | 105.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 76775 | 3 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
14.5¢ |
Change
0.005 ( 7.41 %) |
||||
| Open | High | Low | Volume | ||
| 14.0¢ | 14.5¢ | 13.5¢ | 36575 | ||
| Last updated 13.24pm 06/06/2024 ? | |||||
| OIL (ASX) Chart |